======= AGPAT9 ======= == Gene Information == * **Official Symbol**: GPAT3 * **Official Name**: glycerol-3-phosphate acyltransferase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84803|84803]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q53EU6|Q53EU6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGPAT9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGPAT9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610958|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May transfer the acyl-group from acyl-coA to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis. Also transfers the acyl-group from acyl-coA to the sn-2 position of 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid, or LPA), forming 1,2-diacyl-sn-glycerol-3- phosphate (phosphatidic acid, or PA). {ECO:0000269|PubMed:17002884, ECO:0000269|PubMed:17170135, ECO:0000269|PubMed:19318427}. |Acyltransferase| |sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity| |glycerol-3-phosphate O-acyltransferase activity| |CDP-diacylglycerol biosynthetic process| |CDP-diacylglycerol metabolic process| |1-acylglycerol-3-phosphate O-acyltransferase activity| |triglyceride biosynthetic process| |acylglycerol biosynthetic process| |neutral lipid biosynthetic process| |phosphatidic acid biosynthetic process| |phosphatidic acid metabolic process| |pyrimidine nucleotide biosynthetic process| |pyrimidine-containing compound biosynthetic process| |pyrimidine nucleotide metabolic process| |triglyceride metabolic process| |acylglycerol metabolic process| |neutral lipid metabolic process| |regulation of TOR signaling| |pyrimidine-containing compound metabolic process| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |nucleotide biosynthetic process| |phospholipid biosynthetic process| |nucleoside phosphate biosynthetic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |lipid biosynthetic process| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |endoplasmic reticulum| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |lipid metabolic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp332|Adefovir 20μM R07 exp332]]|-1.85| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|2.08| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.16| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12518 * **Expression level (log2 read counts)**: -1.82 {{:chemogenomics:nalm6 dist.png?nolink |}}